{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:O43927",
      "entity_text" : "CXCL13",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:59174488",
      "entity_text" : "Spebrutinib",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Spebrutinib significantly reduced serum chemokines chemokine ligand 13 (CXCL13), macrophage inflammatory protein-1beta (MIP-1beta), and the bone resorption biomarker carboxy-terminal collagen cross linking telopeptide (CTX-I) (P < 0.05).",
  "reading_complete" : "2020-07-28T16:59:33Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T16:55:57Z",
  "trigger" : "reduced",
  "evidence" : [ "Spebrutinib significantly reduced serum chemokines chemokine ligand 13 (CXCL13" ],
  "pmc_id" : "7021855",
  "score" : 0
}